Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mycobacteriology and Aerobic Actinomycetes

Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead

Leonardo A. Sechi, Maria Gazouli, John Ikonomopoulos, John C. Lukas, Antonio M. Scanu, Niyaz Ahmed, Giovanni Fadda, Stefania Zanetti
Leonardo A. Sechi
1Dipartimento di Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica, Università degli Studi di Sassari, Viale S. Pietro 43/B, 07100 Sassari, Italy
2ISOGEM Collaborative Network on Other Tubercle Bacilli (The International Society for Genomic and Evolutionary Microbiology), Sassari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sechila@uniss.it
Maria Gazouli
3Department of Biology, School of Medicine, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Ikonomopoulos
4Agricultural University of Athens, Department of Anatomy-Physiology, Faculty of Animal Science, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Lukas
5Department of Pharmacology, School of Medicine, Universidad del Pais Vasco, Leioa, Vizcaya, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio M. Scanu
6Clinica Chirurgica, Università degli Studi di Sassari, Viale S. Pietro, 07100 Sassari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niyaz Ahmed
2ISOGEM Collaborative Network on Other Tubercle Bacilli (The International Society for Genomic and Evolutionary Microbiology), Sassari, Italy
8Pathogen Evolution Group, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Fadda
7Istituto di Microbiologia, Facoltà di Medicina e Chirurgia “Agostino Gemelli,” Università Cattolica del Sacro Cuore, 00168 Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefania Zanetti
1Dipartimento di Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica, Università degli Studi di Sassari, Viale S. Pietro 43/B, 07100 Sassari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.43.10.5275-5277.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The present study was performed to determine what proportion of people in Sardinia with or without Crohn's disease were infected with Mycobacterium avium subspecies paratuberculosis and had a preponderance of allelic variants of Nod2, an intracellular protein involved in Crohn's disease susceptibility. Genetic analysis of the alleles of the NOD2/CARD15 gene (insC3020, G908R, and R702W alleles), linked to susceptibility or genetic predisposition to Crohn's disease in humans, was carried out on specimens from 37 Crohn's disease patients and 34 patients without Crohn's disease. Our results show that more than 70 percent of people in Sardinia with Crohn's disease carry at least one of the susceptibility-associated NOD2/CARD15 alleles and were infected with Mycobacterium avium subspecies paratuberculosis.

Recent genetic and epidemiological studies provide suggestive evidence for the presence of genetic determinants of susceptibility to Crohn's disease (CD) and its clinical progression. In a recent report, Behr and colleagues documented the coexistence of Mycobacterium avium subsp. paratuberculosis infection and a permissive NOD2/CARD15 mutant in one individual with CD (1). CD is a disease of unknown etiology linked to immune dysregulation (10). An increasing amount of evidence supports the idea that CD is caused by Mycobacterium avium subsp. paratuberculosis (8, 11, 12). In 2001, three independent mutations within the NOD2/CARD15 gene were discovered to be strongly linked to CD in Europeans (3, 4, 9). According to the observation of Behr et al., the presence of a gene that is associated with an increased susceptibility to develop CD does not preclude the possibility that the disease may be infectious in etiology (1). It is possible that genetically identifiable subpopulations may have different tendencies to develop CD when exposed to the same infectious agent (3, 6). The following case study suggests an exploitation of these considerations in a group of Mediterranean patients with CD.

Endoscopic mucosal biopsy specimens were obtained from 37 patients with CD and 34 individuals without it who were attending the Clinic of Surgery, University of Sassari, for ileocolonoscopy. Biopsy specimens were taken both from the visibly inflamed regions in the patients with inflammatory bowel disease and from several regions throughout the intestines of control subjects. Informed consent for sampling and publication of the results was obtained. Biopsy specimens were examined for the presence of Mycobacterium avium subsp. paratuberculosis and the carriage of NOD2/CARD15 mutations. All the individuals examined were living in Sardinia and were of Sardinian origin. Tissue samples were placed into liquid 7H9 medium, transported directly to the laboratory, and processed within 1 h. One biopsy specimen was used to make a smear and examined by Ziehl-Neelsen and rhodamine-auramine staining as previously described (12).

Samples for PCR analysis for bacterial presence were processed as previously described (7). Primers p89 and p92 described in our previous work (11, 12) were used to amplify a 284-bp fragment specific for Mycobacterium avium subsp. paratuberculosis. The reaction mixture (final volume of 50μ l) comprised primers at a concentration of 0.5 μM, Expand High Fidelity reaction buffer (1×), 200μ M (each) dNTPs, and 3 U of Expand High-Fidelity Taq polymerase (Expand High-fidelity PCR system; Roche, Lewes, United Kingdom). Cycling conditions were 1 cycle of 94°C for 3 min and 36 cycles of 94°C for 40 s, 62°C for 40 s, and 72°C for 40 s, followed by a final step of 72°C for 5 min. Amplified fragments were visualized with ethidium bromide on 2.5% agarose-1000 gel (Life Technologies, Grand Island, NY) and purified with a QIAquick gel extraction kit (QIAGEN, Crawley, United Kingdom). Each amplicon was then sequenced in both directions by using p89 and p92 primers, and the sequences obtained had confirmed 100% homology to the IS900 locus (GenBank accession no. AF416985 ).

Mycobacterium avium subsp. paratuberculosis DNA was detected in 25 CD patients (67.6%) and in 7 controls (20.6%) (Table 1). The results indicated that the presence of Mycobacterium avium subsp. paratuberculosis is significantly associated with CD (P = 0.001; odds ratio [OR], 4.94 [95% confidence interval {CI95 }, 1.85 to 13.29]).

Because of the recently published data showing genetic susceptibility to CD, we also performed genetic testing, aimed at susceptibility-linked alleles of the NOD2/CARD15 gene (insC3020, G908R, and R702W alleles), as previously described (2). Our results indicated that 19 (51.35%) of the CD patients were carriers of at least one of the susceptibility-associated NOD2/CARD15 alleles (10 carried the insC3020 mutation, 8 the R702W mutation, and 6 the G908R mutation), whereas only 7 (20.6%) of the healthy controls carried at least one of the mutated NOD2/CARD15 alleles. A significant association between the carriage of at least one NOD2/CARD15 mutation and development of CD was observed (P = 0.007; OR= 4.07 [CI95, 1.42 to 11.66]). The results confirm for the first time the associations of NOD2/CARD15 mutations and CD in the Sardinian population.

Among the CD patients who carried at least one of the susceptibility-associated NOD2/CARD15 alleles, 14 (73.7%) had evidence for the presence of Mycobacterium avium subsp. paratuberculosis DNA. This association was marginally significant (P < 0.04; OR = 1.7 [CI95, 0.92 to 3.2]) in our study group. Since several findings indicate that the presence of certain bacteria in the face of permissive NOD2/CARD15 mutations is necessary for development of CD (5, 7), it is possible that in individuals with NOD2/CARD15 mutations, the innate response to mycobacterial exposure would be inadequate, permitting establishment of a persistent mycobacterial infection. Chronic infection could then activate the inflammatory response which is characteristic of CD..

Collectively, our findings support and substantiate the suggestions of Behr et al. that these cases may illustrate a potential conceptual approach to CD etiology, mostly based on tandem searches for bacterial trigger and host susceptibility (1). However, further studies involving a larger number of cases and controls on a global scale are clearly needed to elucidate the mechanism behind the etiology of CD.

View this table:
  • View inline
  • View popup
TABLE 1.

Patient detailsa

ACKNOWLEDGMENTS

We thank The Sardinian Region for supporting the research.

FOOTNOTES

    • Received 3 May 2005.
    • Returned for modification 11 July 2005.
    • Accepted 21 July 2005.
  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Behr, M. A., M. Semret, A. Poon, and E. Schurr. 2004 . Crohn's disease, mycobacteria, and NOD2.Lancet Infect. Dis.4:136-137.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Gazouli, M., P. Zacharatos, G. J. Mantzaris, C. Barbatis, I. Ikonomopoulos, A. J. Archimandritis, J. C. Lukas, E. Papalambros, and V. Gorgoulis. 2004. Association of NOD2/CARD15 variants with Crohn's disease in a Greek population.Eur. J. Gastroenterol. Hepatol.16:1177-1182.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Hampe, J., A. Cuthbert, P. J. Croucher, M. M. Mirza, S. Mascheretti, S. Fisher, H. Frenzel, K. King, A. Hasselmeyer, A. J. MacPherson, S. Bridger, S. van Deventer, A. Forbes, S. Nikolaus, J. E. Lennard-Jones, U. R. Foelsch, M. Krawczak, C. Lewis, S. Schreiber, and C. G. Mathew. 2001 . Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.Lancet16:1925-1928.
    OpenUrl
  4. 4.↵
    Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, V. Binder, Y. Finkel, A. Cortot, R. Modigliani, P. Laurent-Puig, C. Gower-Rousseau, J. Macry, J. F. Colombel, M. Sahbatou, and G. Thomas. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.Nature411:599-603.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P Moran, J. L. Fernandez-Luna, and G. Nunez. 2003 . Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem.278:5509-5512.
    OpenUrlPubMed
  6. 6.↵
    Inoue, N., K. Tamura, Y. Kinouchi, Y. Fukuda, S. Takahashi, Y. Ogura, N. Inohara, G. Nunez, Y. Kishi, Y. Koike, T. Shimosegawa, T. Shimoyama, and T. Hibi. 2002. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology123:86-91.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Maeda, S., L. C. Hsu, H. Liu, L. A. Bankston, M. Iimura, M. F. Kagnoff, L. Eckmann, and M. Karin. 2005 . Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science307:734-738.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Naser, S. A., G. Ghobrial, C. Romero, and J. F. Valentine. 2004. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet364:1039-1044.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, J. P. Achkar, S. R. Brant, T. M. Bayless, B. S. Kirschner, S. B. Hanauer, G. Nunez, and J. H. Cho. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature411:603-606.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Podolsky, D. K. 2002. Inflammatory bowel disease.N. Engl. J. Med.347:417-429.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Sechi, L. A., M. Mura, F. Tanda, A. Lissia, A. Solinas, G. Fadda, and S. Zanetti. 2001. Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization. J. Clin. Microbiol.39:4514-4517.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Sechi, L. A., A. M. Scanu, P. Molicotti, S. Cannas, M. Mura, G. Dettori, G. Fadda, and S. Zanetti. 2005. Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am. J. Gastroenterol.100:1529-1536.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead
Leonardo A. Sechi, Maria Gazouli, John Ikonomopoulos, John C. Lukas, Antonio M. Scanu, Niyaz Ahmed, Giovanni Fadda, Stefania Zanetti
Journal of Clinical Microbiology Oct 2005, 43 (10) 5275-5277; DOI: 10.1128/JCM.43.10.5275-5277.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead
Leonardo A. Sechi, Maria Gazouli, John Ikonomopoulos, John C. Lukas, Antonio M. Scanu, Niyaz Ahmed, Giovanni Fadda, Stefania Zanetti
Journal of Clinical Microbiology Oct 2005, 43 (10) 5275-5277; DOI: 10.1128/JCM.43.10.5275-5277.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Crohn Disease
Genetic Predisposition to Disease
Intracellular Signaling Peptides and Proteins
Mycobacterium avium subsp. paratuberculosis
Paratuberculosis

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X